Is a 2.3 x 0.9 x 1.6 cm hypoechoic structure in the left lateral uterine wall suggestive of a uterine fibroid (Leiomyoma) and an indication for Cesarean Section (CS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The presence of a hypoechoic structure measuring 2.3 x 0.9 x 1.6cm in the left lateral uterine wall is highly suggestive of a uterine fibroid, which may be a consideration for cesarean section (CS) if it is deemed to be impacting fetal delivery or uterine integrity 1.

Key Considerations

  • Patients with symptomatic fibroids may be managed with medications such as gonadotropin-releasing hormone (GnRH) agonists, like leuprolide acetate 3.75mg IM every 4 weeks, or non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen 400-800mg orally every 8 hours, for symptom control 1.
  • The decision for CS should be individualized based on factors such as fibroid size, location, and patient-specific obstetric risk factors 1.
  • Pelvic ultrasound and MRI are the best imaging modalities for the initial diagnosis of fibroids, the initial treatment of known fibroids, and for surveillance or post-treatment imaging 1.
  • The size and location of the fibroid, as well as the patient's obstetric history and symptom severity, should be taken into account when determining the best course of treatment 1.

Treatment Options

  • Medical therapy: GnRH agonists, levonorgestrel-releasing intrauterine devices, contraceptive steroid hormones, and tranexamic acid 1.
  • Uterine sparing therapies: myomectomy, endometrial ablation, uterine fibroid embolization (UFE), MR-guided focused ultrasound (MRgFUS), and laparoscopic radiofrequency ablation 1.
  • Hysterectomy: curative, but should be considered only after other treatment options have been explored 1.

From the Research

Uterine Fibroid (Leiomyoma) Diagnosis

  • A 2.3 x 0.9 x 1.6 cm hypoechoic structure in the left lateral uterine wall may be suggestive of a uterine fibroid (Leiomyoma) based on its size and location, but the provided studies do not directly address this topic.
  • The studies provided focus on lymph node size, endometrial thickness, liver echogenicity, thyroid nodule size, and upper abdominal lymph nodes, which are not directly relevant to the diagnosis of uterine fibroids.

Indication for Cesarean Section (CS)

  • There is no direct evidence in the provided studies to suggest that a 2.3 x 0.9 x 1.6 cm hypoechoic structure in the left lateral uterine wall is an indication for Cesarean Section (CS) 2, 3, 4, 5, 6.
  • The decision for a Cesarean Section is typically based on various factors, including the size and location of the fibroid, as well as the individual patient's medical history and pregnancy complications, which are not addressed in the provided studies.

Relevance of Provided Studies

  • The provided studies do not directly address the topic of uterine fibroids or indications for Cesarean Section, and therefore, do not provide relevant evidence to answer the question 2, 3, 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2004

Research

Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002

Research

Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.

Thyroid : official journal of the American Thyroid Association, 2017

Related Questions

What are the implications of an endometrium thickness of 1.7cm and how should it be managed?
What is the significance of mildly elevated liver enzymes, including Alanine Transaminase (ALT) of 139, Alkaline Phosphatase (ALP) of 87, and Aspartate Transaminase (AST) of 106, in a 24-year-old female with incidental hepatic steatosis (fatty liver disease) on abdominal ultrasound, negative Hepatitis screen, normal Bilirubin, and normal International Normalized Ratio (INR)?
Does a 0.1 cm increase in size of a previously benign (in 2018) 3.1 cm thyroid nodule (TR4) to 3.2 cm warrant a re-biopsy?
From which thyroid nodule (Fine Needle Aspiration) FNA should be taken in a patient with a 2x1cm mass on the right side and a 3x2cm mass on the left side?
Is a 14mm thick uterus with a very light period for only 2 days normal and what investigations should be done?
What are the risks and contraindications of administering multiple antipsychotics, including Latuda (lurasidone), Zyprexa (olanzapine), Haldol (haloperidol), and Thorazine (chlorpromazine), to an adult patient with a genetically confirmed resistance to psychosis, suspected Attention Deficit Hyperactivity Disorder (ADHD), and intersex condition, who has reported sexual abuse and harassment by staff, and is being denied their right to fill out an Advanced Directive/Power of Attorney (PoA)?
What are the risks and contraindications of administering multiple antipsychotics, including Latuda (lurasidone), Zyprexa (olanzapine), Haldol (haloperidol), and Thorazine (chlorpromazine), to an adult patient with a genetically confirmed resistance to psychosis, suspected Attention Deficit Hyperactivity Disorder (ADHD), and intersex condition, who has reported sexual abuse and harassment by staff, and is being denied their right to fill out an Advanced Directive/Power of Attorney (PoA)?
What are the risks and contraindications of administering multiple antipsychotics, including Latuda (lurasidone), Zyprexa (olanzapine), Haldol (haloperidol), and Thorazine (chlorpromazine), to an adult patient with a genetically confirmed resistance to psychosis, suspected Attention Deficit Hyperactivity Disorder (ADHD), and intersex condition, who has reported sexual abuse and harassment by staff, and is being denied their right to fill out an Advanced Directive/Power of Attorney (PoA)?
What medication is used for lower gastrointestinal (GI) bleeding?
What is the principle behind combining corticosteroids (steroids) with other medications in ophthalmic eye drops, rather than using corticosteroids alone?
Can Tamiflu (Oseltamivir) be given rectally?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.